Home Other Building Blocks 611-59-6
611-59-6,MFCD00005727
Catalog No.:AA003TH8

611-59-6 | 1,7-Dimethyl-1H-purine-2,6(3H,7H)-dione

Pack Size
Purity
Availability
Price(USD)
Quantity
  
10mg
≥98%
in stock  
$63.00   $44.00
- +
25mg
≥98%
in stock  
$118.00   $82.00
- +
50mg
≥98%
in stock  
$169.00   $118.00
- +
100mg
>98.0%(HPLC)
in stock  
$228.00   $160.00
- +
1g
95%
in stock  
$1,635.00   $1,144.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA003TH8
Chemical Name:
1,7-Dimethyl-1H-purine-2,6(3H,7H)-dione
CAS Number:
611-59-6
Molecular Formula:
C7H8N4O2
Molecular Weight:
180.1640
MDL Number:
MFCD00005727
SMILES:
Cn1cnc2c1c(=O)n(c(=O)[nH]2)C
NSC Number:
400018
Properties
Properties
 
BP:
312.97°C (rough estimate)  
Form:
Solid  
MP:
294-296 °C(lit.)  
Refractive Index:
1.6700 (estimate)  
Solubility:
ethanol: 0.6mg/mL  
Storage:
Keep in dry area;2-8℃;  

Computed Properties
 
Complexity:
267  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
13  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
XLogP3:
-0.2  

Downstream Synthesis Route

[1]MonatsheftefurChemie,1985,vol.116,p.341-352

[2]MonatsheftefurChemie,1985,vol.116,p.341-352

[3]MonatsheftefurChemie,1985,vol.116,p.341-352

[4]MonatsheftefurChemie,1985,vol.116,p.341-352

[1]ChemicalCommunications,2017,vol.53,p.3637-3640

[2]Patent:WO2018/157800,2018,A1.Locationinpatent:Paragraph0613-0614;0725-0726

[1]Patent:CN109503583,2019,A

[2]Patent:CN109503583,2019,A

[3]Patent:CN109503583,2019,A

[4]Patent:CN109503583,2019,A

[5]Patent:CN109503583,2019,A

[6]Patent:CN109503583,2019,A

[7]Patent:CN109503583,2019,A

[8]Patent:CN109503583,2019,A

[9]Patent:CN109503583,2019,A

[10]Patent:CN109503583,2019,A

[11]Patent:CN109503583,2019,A

[12]Patent:CN109503583,2019,A

[13]Patent:CN109503583,2019,A

[14]Patent:CN109503583,2019,A

[15]Patent:CN109503583,2019,A

[16]Patent:CN109503583,2019,A

[17]Patent:CN109503583,2019,A

[18]Patent:CN109503583,2019,A

[19]Patent:CN109503583,2019,A

[20]Patent:CN109503583,2019,A

[21]Patent:CN109503583,2019,A

Literature

Title: Ultrasound-assisted matrix solid phase dispersive extraction for the simultaneous analysis of β-lactams (four penicillins and eight cephalosporins) in milk by high performance liquid chromatography with photodiode array detection.

Journal: Journal of separation science 20121001

Title: Ultrafast nonradiative decay by hypoxanthine and several methylxanthines in aqueous and acetonitrile solution.

Journal: Physical chemistry chemical physics : PCCP 20120814

Title: Cocktail approach for in vivo phenotyping of 5 major CYP450 isoenzymes: development of an effective sampling, extraction, and analytical procedure and pilot study with comparative genotyping.

Journal: Journal of clinical pharmacology 20120801

Title: Measurement of CYP1A2 activity: a focus on caffeine as a probe.

Journal: Current drug metabolism 20120601

Title: Effect of Ginkgo biloba special extract EGb 761® on human cytochrome P450 activity: a cocktail interaction study in healthy volunteers.

Journal: European journal of clinical pharmacology 20120501

Title: High-sensitivity liquid chromatography-tandem mass spectrometry for the simultaneous determination of five drugs and their cytochrome P450-specific probe metabolites in human plasma.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120501

Title: Caffeine as an indicator for the quantification of untreated wastewater in karst systems.

Journal: Water research 20120201

Title: Effects of a caffeine-containing energy drink on simulated soccer performance.

Journal: PloS one 20120101

Title: The influence of a CYP1A2 polymorphism on the ergogenic effects of caffeine.

Journal: Journal of the International Society of Sports Nutrition 20120101

Title: Analysis of anti-inflammatory, analgesic, stimulant and antidepressant drugs in purified water from wastewater treatment plants using SPE-LC tandem mass spectrometry.

Journal: Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering 20120101

Title: Concordant signaling pathways produced by pesticide exposure in mice correspond to pathways identified in human Parkinson's disease.

Journal: PloS one 20120101

Title: Caffeine reduces 11β-hydroxysteroid dehydrogenase type 2 expression in human trophoblast cells through the adenosine A(2B) receptor.

Journal: PloS one 20120101

Title: Oral application of 1,7-dimethylxanthine (paraxanthine) attenuates the formation of experimental cholestatic liver fibrosis.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology 20111101

Title: High-resolution mass spectrometry method for the detection, characterization and quantitation of pharmaceuticals in water.

Journal: Journal of mass spectrometry : JMS 20111101

Title: Pharmacokinetics of caffeine in plasma and saliva, and the influence of caffeine abstinence on CYP1A2 metrics.

Journal: The Journal of pharmacy and pharmacology 20110901

Title: Caffeine and insulin resistance in pregnancy.

Journal: American journal of perinatology 20110801

Title: Measurements of caffeine and plasma metabolite/caffeine ratios as a test for hepatic drug-oxidizing capacity in goats.

Journal: Xenobiotica; the fate of foreign compounds in biological systems 20110701

Title: Perinatal asphyxia: current status and approaches towards neuroprotective strategies, with focus on sentinel proteins.

Journal: Neurotoxicity research 20110501

Title: Disposition kinetics of caffeine and paraxanthine in Nile tilapia (Oreochromis niloticus): characterization of the main metabolites.

Journal: Archives of environmental contamination and toxicology 20110501

Title: Clinical and physiological correlates of caffeine and caffeine metabolites in primary insomnia.

Journal: Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20110415

Title: A simple chromatographic method for determining norfloxacin and enoxacin in pharmacokinetic study assessing CYP1A2 inhibition.

Journal: Biomedical chromatography : BMC 20110401

Title: Genistein alters caffeine exposure in healthy female volunteers.

Journal: European journal of clinical pharmacology 20110401

Title: Evaluation of the reproductive and developmental risks of caffeine.

Journal: Birth defects research. Part B, Developmental and reproductive toxicology 20110401

Title: Genome-wide meta-analysis identifies regions on 7p21 (AHR) and 15q24 (CYP1A2) as determinants of habitual caffeine consumption.

Journal: PLoS genetics 20110401

Title: New specific marker of cytochrome P450 1A2 activity.

Journal: Bulletin of experimental biology and medicine 20110401

Title: Evaluation of selected ubiquitous contaminants in the aquatic environment and their transformation products. A pilot study of their removal from a sewage treatment plant.

Journal: Water research 20110301

Title: Cognitive slowing associated with elevated serum anticholinergic activity in older individuals is decreased by caffeine use.

Journal: The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20110201

Title: Characterization of a broad-specificity non-haem iron N-demethylase from Pseudomonas putida CBB5 capable of utilizing several purine alkaloids as sole carbon and nitrogen source.

Journal: Microbiology (Reading, England) 20110201

Title: Comparative pharmacokinetics and metabolisms of caffeine in sheep breeds.

Journal: The Journal of veterinary medical science 20110101

Title: Pharmacokinetics and metabolism of natural methylxanthines in animal and man.

Journal: Handbook of experimental pharmacology 20110101

Title: Distribution of nonprescription pharmaceuticals in central Indiana streams and effects on sediment microbial activity.

Journal: Ecotoxicology (London, England) 20110101

Title: Effects of rutaecarpine on the metabolism and urinary excretion of caffeine in rats.

Journal: Archives of pharmacal research 20110101

Title: Effects of caffeinated and decaffeinated coffee on biological risk factors for type 2 diabetes: a randomized controlled trial.

Journal: Nutrition journal 20110101

Title: Energy drinks and the neurophysiological impact of caffeine.

Journal: Frontiers in neuroscience 20110101

Title: The promise of neuroprotective agents in Parkinson's disease.

Journal: Frontiers in neurology 20110101

Title: Caffeine and paraxanthine HPLC assay for CYP1A2 phenotype assessment using saliva and plasma.

Journal: Biomedical chromatography : BMC 20101001

Title: Occurrence of emerging contaminants, priority substances (2008/105/CE) and heavy metals in treated wastewater and groundwater at Depurbaix facility (Barcelona, Spain).

Journal: The Science of the total environment 20100801

Title: Effects of the aqueous extract from Salvia miltiorrhiza Bunge on caffeine pharmacokinetics and liver microsomal CYP1A2 activity in humans and rats.

Journal: The Journal of pharmacy and pharmacology 20100801

Title: Effects of paraxanthine and caffeine on sleep, locomotor activity, and body temperature in orexin/ataxin-3 transgenic narcoleptic mice.

Journal: Sleep 20100701

Title: Plant polyphenol curcumin significantly affects CYP1A2 and CYP2A6 activity in healthy, male Chinese volunteers.

Journal: The Annals of pharmacotherapy 20100601

Title: Neuroprotection by caffeine: time course and role of its metabolites in the MPTP model of Parkinson's disease.

Journal: Neuroscience 20100505

Title: Caffeine improves supramaximal cycling but not the rate of anaerobic energy release.

Journal: European journal of applied physiology 20100501

Title: Inhibition of acute pulmonary and systemic inflammation by 1,7-dimethylxanthine.

Journal: European journal of pharmacology 20100310

Title: Zirconia based monoliths used in hydrophilic-interaction chromatography for original selectivity of xanthines.

Journal: Journal of chromatography. A 20100226

Title: Production and characterization of a genetically engineered anti-caffeine camelid antibody and its use in immunoaffinity chromatography.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20100115

Title: Occurrence of emerging pollutants in urban wastewater and their removal through biological treatment followed by ozonation.

Journal: Water research 20100101

Title: Inhibition of CTP synthase from Escherichia coli by xanthines and uric acids.

Journal: Bioorganic & medicinal chemistry letters 20100101

Title: Coffee consumption and CYP1A2 genotype in relation to bone mineral density of the proximal femur in elderly men and women: a cohort study.

Journal: Nutrition & metabolism 20100101

Title: International society of sports nutrition position stand: caffeine and performance.

Journal: Journal of the International Society of Sports Nutrition 20100101

Title: Oxidative stress in lens in vivo: inhibitory effect of caffeine. A preliminary report.

Journal: Molecular vision 20100101

Title: Molecular and cellular designs of insect taste receptor system.

Journal: Frontiers in cellular neuroscience 20100101

Title: Fate of effluent-borne contaminants beneath septic tank drainfields overlying a Karst aquifer.

Journal: Journal of environmental quality 20100101

Title: Caffeine's Vascular Mechanisms of Action.

Journal: International journal of vascular medicine 20100101

Title: Drug metabolizing enzyme CYP1A2 status in pediatric patients with hemoglobin E-beta thalassemia.

Journal: Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20091201

Title: Less Smad2 is good for you! A scientific update on coffee's liver benefits.

Journal: Hepatology (Baltimore, Md.) 20090901

Title: Simultaneous action of the flavonoid quercetin on cytochrome P450 (CYP) 1A2, CYP2A6, N-acetyltransferase and xanthine oxidase activity in healthy volunteers.

Journal: Clinical and experimental pharmacology & physiology 20090801

Title: Effects of major tanshinones isolated from Danshen (Salvia miltiorrhiza) on rat CYP1A2 expression and metabolism of model CYP1A2 probe substrates.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology 20090801

Title: Occurrence of selected pharmaceuticals in an agricultural landscape, western Lake Erie basin.

Journal: Water research 20090801

Title: Hapten-induced dimerization of a single-domain VHH camelid antibody.

Journal: Biochemistry 20090728

Title: Identification of paraxanthine as the most potent caffeine-derived inhibitor of connective tissue growth factor expression in liver parenchymal cells.

Journal: Liver international : official journal of the International Association for the Study of the Liver 20090701

Title: Two distinct pathways for metabolism of theophylline and caffeine are coexpressed in Pseudomonas putida CBB5.

Journal: Journal of bacteriology 20090701

Title: Effect of sodium tanshinone II A sulfonate on the activity of CYP1A2 in healthy volunteers.

Journal: Xenobiotica; the fate of foreign compounds in biological systems 20090701

Title: Waste-indicator and pharmaceutical compounds in landfill-leachate-affected ground water near Elkhart, Indiana, 2000-2002.

Journal: Bulletin of environmental contamination and toxicology 20090601

Title: Influence of genetic polymorphisms, smoking, gender and age on CYP1A2 activity in a Turkish population.

Journal: Pharmacogenomics 20090501

Title: Caffeine metabolic ratios for the in vivo evaluation of CYP1A2, N-acetyltransferase 2, xanthine oxidase and CYP2A6 enzymatic activities.

Journal: Current drug metabolism 20090501

Title: Removal of organic wastewater contaminants in septic systems using advanced treatment technologies.

Journal: Journal of environmental quality 20090101

Title: Regulation of cerebrospinal fluid production by caffeine consumption.

Journal: BMC neuroscience 20090101

Title: [On the possibility of patient phenotyping on the basis of cytochrome p-450 1A2 isoenzyme activity using caffeine as the test substrate].

Journal: Eksperimental'naia i klinicheskaia farmakologiia 20090101

Title: Pathophysiological changes that affect drug disposition in protein-energy malnourished children.

Journal: Nutrition & metabolism 20090101

Title: Systemic 7-methylxanthine in retarding axial eye growth and myopia progression: a 36-month pilot study.

Journal: Journal of ocular biology, diseases, and informatics 20081201

Title: Assessing caffeine exposure in pregnant women.

Journal: The British journal of nutrition 20081001

Title: Paraxanthine, the primary metabolite of caffeine, provides protection against dopaminergic cell death via stimulation of ryanodine receptor channels.

Journal: Molecular pharmacology 20081001

Title: A national reconnaissance for pharmaceuticals and other organic wastewater contaminants in the United States--II) untreated drinking water sources.

Journal: The Science of the total environment 20080901

Title: Metabolite profiling of human amniotic fluid by hyphenated nuclear magnetic resonance spectroscopy.

Journal: Analytical chemistry 20080801

Title: Occurrence of psychoactive stimulatory drugs in wastewaters in north-eastern Spain.

Journal: The Science of the total environment 20080701

Title: CYP2A6 activity in a healthy Spanish population: effect of age, sex, smoking, and oral contraceptives.

Journal: Human & experimental toxicology 20080501

Title: Induction of in vitro EROD activity and in vivo caffeine metabolism in two species of New Zealand birds.

Journal: Environmental toxicology and pharmacology 20080501

Title: Prenatal caffeine assessment: fetal and maternal biomarkers or self-reported intake?

Journal: Annals of epidemiology 20080301

Title: Increases in cerebrospinal fluid caffeine concentration are associated with favorable outcome after severe traumatic brain injury in humans.

Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20080201

Title: Perinatal dioxin exposure, cytochrome P-450 activity, liver functions and thyroid hormones at follow-up after 7-12 years.

Journal: Chemosphere 20080201

Title: Growth hormone does not alter CYP2A6 activity in growth hormone-deficient children.

Journal: Basic & clinical pharmacology & toxicology 20080101

Title: Effects of gender and moderate smoking on the pharmacokinetics and effects of the CYP1A2 substrate tizanidine.

Journal: European journal of clinical pharmacology 20080101

Title: Interaction profile of armodafinil with medications metabolized by cytochrome P450 enzymes 1A2, 3A4 and 2C19 in healthy subjects.

Journal: Clinical pharmacokinetics 20080101

Title: Biomonitoring of complex occupational exposures to carcinogens: the case of sewage workers in Paris.

Journal: BMC cancer 20080101

Title: Maternal caffeine intake during pregnancy and risk of fetal growth restriction: a large prospective observational study.

Journal: BMJ (Clinical research ed.) 20080101

Title: Perinatal caffeine, acting on maternal adenosine A(1) receptors, causes long-lasting behavioral changes in mouse offspring.

Journal: PloS one 20080101

Title: Polymorphisms of GSTP1 and GSTT1, but not of CYP2A6, CYP2E1 or GSTM1, modify the risk for esophageal cancer in a western population.

Journal: Carcinogenesis 20071201

Title: Association between caffeine intake and risk of Parkinson's disease among fast and slow metabolizers.

Journal: Pharmacogenetics and genomics 20071101

Title: Caffeine-activated large-conductance plasma membrane cation channels in cardiac myocytes: characteristics and significance.

Journal: American journal of physiology. Heart and circulatory physiology 20071001

Title: Simultaneous analysis of neutral and acidic pharmaceuticals as well as related compounds by gas chromatography-tandem mass spectrometry in wastewater.

Journal: Talanta 20070915

Title: Distributions of pharmaceuticals in an urban estuary during both dry- and wet-weather conditions.

Journal: Environmental science & technology 20070815

Title: Reduction in non-glomerular renal clearance of the caffeine metabolite 1-methylxanthine by probenecid.

Journal: International journal of clinical pharmacology and therapeutics 20070801

Title: Ultraperformance liquid chromatography-tandem mass spectrometry analysis of stimulatory drugs of abuse in wastewater and surface waters.

Journal: Analytical chemistry 20070515

Title: HPLC determination of caffeine and paraxanthine in urine: An assay for cytochrome P450 1A2 activity.

Journal: Biochemistry and molecular biology education : a bimonthly publication of the International Union of Biochemistry and Molecular Biology 20070301

Title: In vivo evaluation of CYP1A2, CYP2A6, NAT-2 and xanthine oxidase activities in a Greek population sample by the RP-HPLC monitoring of caffeine metabolic ratios.

Journal: Biomedical chromatography : BMC 20070201

Title: Appropriate phenotyping procedures for drug metabolizing enzymes and transporters in humans and their simultaneous use in the 'cocktail' approach.

Journal: Clinical pharmacology and therapeutics 20070201

Title: Development of a biosensor for caffeine.

Journal: Analytica chimica acta 20070123

Title: Pilot survey monitoring pharmaceuticals and related compounds in a sewage treatment plant located on the Mediterranean coast.

Journal: Chemosphere 20070101

Title: Pharmaceuticals in on-site sewage effluent and ground water, Western Montana.

Journal: Ground water 20070101

Title: Effect of diet on the development of drug metabolism by cytochrome P-450 enzymes in healthy infants.

Journal: Pediatric research 20061201

Title: Awareness and use of caffeine by athletes competing at the 2005 Ironman Triathlon World Championships.

Journal: International journal of sport nutrition and exercise metabolism 20061001

Title: Caffeine metabolites are inhibitors of the nuclear enzyme poly(ADP-ribose)polymerase-1 at physiological concentrations.

Journal: Biochemical pharmacology 20060928

Title: Immunomodulatory effects of caffeine: friend or foe?

Journal: Pharmacology & therapeutics 20060901

Title: Liver disease selectively modulates cytochrome P450--mediated metabolism.

Journal: Clinical pharmacology and therapeutics 20060901

Title: Steroid estrogens, nonylphenol ethoxylate metabolites, and other wastewater contaminants in groundwater affected by a residential septic system on Cape Cod, MA.

Journal: Environmental science & technology 20060815

Title: Caffeine metabolites in umbilical cord blood, cytochrome P-450 1A2 activity, and intrauterine growth restriction.

Journal: American journal of epidemiology 20060601

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Title: [Determination of the activity of cytochrome P-450 CYP2A6 by HPLC method with caffeine as metabolizing probe].

Journal: Yao xue xue bao = Acta pharmaceutica Sinica 20060301

Title: Oxidation of caffeine by CYP1A2: isotope effects and metabolic switching.

Journal: Drug metabolism and disposition: the biological fate of chemicals 20051201

Title: Artemisinin and thiabendazole are potent inhibitors of cytochrome P450 1A2 (CYP1A2) activity in humans.

Journal: European journal of clinical pharmacology 20051101

Title: Oral contraceptives containing ethinyl estradiol and gestodene markedly increase plasma concentrations and effects of tizanidine by inhibiting cytochrome P450 1A2.

Journal: Clinical pharmacology and therapeutics 20051001

Title: Cyp2a6 is a principal enzyme involved in hydroxylation of 1,7-dimethylxanthine, a main caffeine metabolite, in humans.

Journal: Drug metabolism and disposition: the biological fate of chemicals 20050901

Title: Cytochrome P450 mRNA expression in peripheral blood lymphocytes as a predictor of enzyme induction.

Journal: European journal of clinical pharmacology 20050901

Title: Assessment of CYP1A2 activity in clinical practice: why, how, and when?

Journal: Basic & clinical pharmacology & toxicology 20050901

Title: Inhibition of HIV-1 replication by caffeine and caffeine-related methylxanthines.

Journal: Virology 20050510

Title: No relevant interaction with alprazolam, caffeine, tolbutamide, and digoxin by treatment with a low-hyperforin St John's wort extract.

Journal: Planta medica 20050401

Title: PCB exposure and in vivo CYP1A2 activity among Native Americans.

Journal: Environmental health perspectives 20050301

Title: Association between CYP1A2 activity and riluzole clearance in patients with amyotrophic lateral sclerosis.

Journal: British journal of clinical pharmacology 20050301

Title: Capillary electrochromatography of caffeine and its metabolites in rat brain microdialysate.

Journal: Electrophoresis 20050201

Title: Population pharmacokinetics of caffeine and its metabolites theobromine, paraxanthine and theophylline after inhalation in combination with diacetylmorphine.

Journal: Basic & clinical pharmacology & toxicology 20050101

Title: Determination of methylxanthines in urine by liquid chromatography with diode array UV detection.

Journal: Journal of pharmaceutical and biomedical analysis 20041115

Title: Evidence for concurrent effects of exposure to environmental cadmium and lead on hepatic CYP2A6 phenotype and renal function biomarkers in nonsmokers.

Journal: Environmental health perspectives 20041101

Title: Caffeine suppresses TNF-alpha production via activation of the cyclic AMP/protein kinase A pathway.

Journal: International immunopharmacology 20041001

Title: Separation, pre-concentration, and HPLC analysis of methylxanthines in urine samples.

Journal: Journal of separation science 20041001

Title: Inhibition of the human organic anion transporter 1 by the caffeine metabolite 1-methylxanthine.

Journal: Biochemical and biophysical research communications 20040716

Title: Catabolism of caffeine in plants and microorganisms.

Journal: Frontiers in bioscience : a journal and virtual library 20040501

Title: Salivary caffeine metabolic ratio in alcohol-dependent subjects.

Journal: European journal of clinical pharmacology 20040401

Title: Serum metabolite/caffeine ratios as a test for liver function.

Journal: Journal of clinical pharmacology 20040401

Title: Regarding 'An unexpected distribution of sodium concentration in serum specimens stored for more than 30 years'.

Journal: Annals of epidemiology 20040101

Title: Effect of caffeine-containing versus decaffeinated coffee on serum clozapine concentrations in hospitalised patients.

Journal: Basic & clinical pharmacology & toxicology 20040101

Title: Rapid determination of five probe drugs and their metabolites in human plasma and urine by liquid chromatography/tandem mass spectrometry: application to cytochrome P450 phenotyping studies.

Journal: Rapid communications in mass spectrometry : RCM 20040101

Title: Effects of caffeine intake on the pharmacokinetics of melatonin, a probe drug for CYP1A2 activity.

Journal: British journal of clinical pharmacology 20031201

Title: Induction of the procarcinogen-activating CYP1A2 by a herbal dietary supplement in rats and humans.

Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20030601

Title: Two novel methods for the determination of CYP1A2 activity using the paraxanthine/caffeine ratio.

Journal: Fundamental & clinical pharmacology 20030601

Title: Paraxanthine/caffeine ratio: as an index for CYP1A2 activity in polycyclic aromatic hydrocarbons exposed subjects.

Journal: Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20030601

Title: Effect of naturally occurring plant phenolics on the induction of drug metabolizing enzymes by o-toluidine.

Journal: Toxicology 20030415

Title: Effect of a divided caffeine dose on endurance cycling performance, postexercise urinary caffeine concentration, and plasma paraxanthine.

Journal: Journal of applied physiology (Bethesda, Md. : 1985) 20030401

Title: Isozyme-specific induction of low-dose aspirin on cytochrome P450 in healthy subjects.

Journal: Clinical pharmacology and therapeutics 20030301

Title: Antagonism of adenosine receptors by caffeine and caffeine metabolites in equine forebrain tissues.

Journal: American journal of veterinary research 20030201

Title: Novel markers of susceptibility to carcinogens in diet: associations with colorectal cancer.

Journal: Toxicology 20021227

Title: Inducibility of CYP1A2 by omeprazole in vivo related to the genetic polymorphism of CYP1A2.

Journal: British journal of clinical pharmacology 20021101

Title: Effects of exercise and thermal stress on caffeine pharmacokinetics in men and eumenorrheic women.

Journal: Journal of applied physiology (Bethesda, Md. : 1985) 20021001

Title: Caffeine potentiates the discriminative-stimulus effects of nicotine in rats.

Journal: Psychopharmacology 20020801

Title: Severe 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) intoxication: insights into the measurement of hepatic cytochrome P450 1A2 induction.

Journal: Clinical pharmacology and therapeutics 20020801

Title: Differences in caffeine and paraxanthine metabolism between human and murine CYP1A2.

Journal: Biochemical pharmacology 20020615

Title: [Research on the separation of caffeine and its nine analogues by micellar electrokinetic capillary chromatography].

Journal: Se pu = Chinese journal of chromatography 20020501

Title: Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.

Journal: The Journal of biological chemistry 20020419

Title: CYP2A6 activity determined by caffeine phenotyping: association with colorectal cancer risk.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20020401

Title: Heterogeneity in assessing self-reports of caffeine exposure: implications for studies of health effects.

Journal: Epidemiology (Cambridge, Mass.) 20020301

Title: Maternal serum caffeine metabolites and small-for-gestational age birth.

Journal: American journal of epidemiology 20020101

Title: Determination of theophylline by HPLC and GC-IDMS, the effect of chemically similar xanthine derivatives on the specificity of the method and the possibility of paracetamol as interfering substance.

Journal: Clinical laboratory 20020101

Title: Caffeine test in predicting flutamide-induced hepatic injury in patients with prostate cancer.

Journal: Prostate cancer and prostatic diseases 20020101

Title: Structural basis for the binding affinity of xanthines with the DNA intercalator acridine orange.

Journal: Journal of medicinal chemistry 20011220

Title: Physiologic hyperinsulinemia enhances human skeletal muscle perfusion by capillary recruitment.

Journal: Diabetes 20011201

Title: Urinary biomarkers for assessing dietary exposure to caffeine.

Journal: Food additives and contaminants 20011201

Title: Variability of cytochrome P450 1A2 activity over time in young and elderly healthy volunteers.

Journal: British journal of clinical pharmacology 20011101

Title: [Clinical study of a new expander with an agent delivery system and the effect of a chemical agent on tissue expansion].

Journal: Zhonghua zheng xing wai ke za zhi = Zhonghua zhengxing waike zazhi = Chinese journal of plastic surgery 20011101

Title: Olanzapine disposition in humans is unrelated to CYP1A2 and CYP2D6 phenotypes.

Journal: European journal of clinical pharmacology 20010901

Title: Use of novel solid-phase extraction sorbent materials for high-performance liquid chromatography quantitation of caffeine metabolism products methylxanthines and methyluric acids in samples of biological origin.

Journal: Journal of chromatography. B, Biomedical sciences and applications 20010815

Title: The effect of pregnancy on cytochrome P4501A2, xanthine oxidase, and N-acetyltransferase activities in humans.

Journal: Clinical pharmacology and therapeutics 20010801

Title: Uncertainty factors for chemical risk assessment: interspecies differences in the in vivo pharmacokinetics and metabolism of human CYP1A2 substrates.

Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20010701

Title: Uncertainty factors for chemical risk assessment. human variability in the pharmacokinetics of CYP1A2 probe substrates.

Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20010701

Title: In vivo effect of clarithromycin on multiple cytochrome P450s.

Journal: Drug metabolism and disposition: the biological fate of chemicals 20010701

Title: In vivo inhibition of human CYP1A2 activity by oltipraz.

Journal: Cancer chemotherapy and pharmacology 20010601

Title: High-performance liquid chromatographic assay for acetaminophen glucuronide in human liver microsomes.

Journal: Journal of chromatography. B, Biomedical sciences and applications 20010405

Title: 7-Methylxanthine methyltransferase of coffee plants. Gene isolation and enzymatic properties.

Journal: The Journal of biological chemistry 20010316

Title: Cytosolic xanthine oxidoreductase mediated bioactivation of ethanol to acetaldehyde and free radicals in rat breast tissue. Its potential role in alcohol-promoted mammary cancer.

Journal: Toxicology 20010307

Title: Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells.

Journal: Biochemical pharmacology 20010215

Title: Determination of urinary methylated purine pattern by high-performance liquid chromatography.

Journal: Journal of chromatography. B, Biomedical sciences and applications 20010210

Title: [Use of the paraxanthine/caffeine ratio in the saliva of patients with liver cirrhosis].

Journal: Casopis lekaru ceskych 20010201

Title: Caffeine metabolism before and after liver transplantation.

Journal: International journal of clinical pharmacology and therapeutics 20010201

Title: Caffeine metabolism in a group of 67 patients with primary biliary cirrhosis.

Journal: International journal of clinical pharmacology and therapeutics 20010101

Title: Rat ventral prostate xanthine oxidase bioactivation of ethanol to acetaldehyde and 1-hydroxyethyl free radicals: analysis of its potential role in heavy alcohol drinking tumor-promoting effects.

Journal: Teratogenesis, carcinogenesis, and mutagenesis 20010101

Title: Effects of phenothiazine neuroleptics on the rate of caffeine demethylation and hydroxylation in the rat liver.

Journal: Polish journal of pharmacology 20010101

Title: Synthesis of paraxanthine analogs (1,7-disubstituted xanthines) and other xanthines unsubstituted at the 3-position: structure-activity relationships at adenosine receptors.

Journal: Journal of medicinal chemistry 19931029

Title: Caffeine, estradiol, and progesterone interact with human CYP1A1 and CYP1A2. Evidence from cDNA-directed expression in Saccharomyces cerevisiae.

Journal: Drug metabolism and disposition: the biological fate of chemicals 19930101

Title: Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1.

Journal: Pharmacogenetics 19920401

Title: Guerreiro S, et al. Paraxanthine, the primary metabolite of caffeine, provides protection against dopaminergic cell death via stimulation of ryanodine receptor channels. Mol Pharmacol. 2008 Oct;74(4):980-9.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:611-59-6 Molecular Formula|611-59-6 MDL|611-59-6 SMILES|611-59-6 1,7-Dimethyl-1H-purine-2,6(3H,7H)-dione